PMID: 2121904Dec 1, 1990Paper

Aluminum inhibits calpain-mediated proteolysis and induces human neurofilament proteins to form protease-resistant high molecular weight complexes

Journal of Neurochemistry
R A NixonF Grynspan

Abstract

We studied the effects of aluminum salts on the degradation of human neurofilament subunits (NF-H, NF-M, and NF-L, the high, middle, and low molecular weight subunits, respectively) and other cytoskeletal proteins using calcium-activated neutral proteinase (calpain) purified from human brain. Calpain-mediated proteolysis of NF-L, tubulin, and glial fibrillary acidic protein (GFAP), three substrates that displayed constant digestion rates in vitro, was inhibited by AlCl3 (IC50 = 200 microM) and by aluminum lactate (IC50 = 400 microM). Aluminum salts inhibited proteolysis principally by affecting the substrates directly. After exposure to 400 microM aluminum lactate and removal of unbound aluminum, human cytoskeletal proteins were degraded two- to threefold more slowly by calpain. When cytoskeleton preparations were exposed to aluminum salt concentrations of 100 microM or higher, proportions of NF-M and NF-H formed urea-insoluble complexes of high apparent molecular mass, which were also resistant to proteolysis by calpain. Complexes of tubulin and of GFAP were not observed under the same conditions. Aluminum salts irreversibly inactivated calpain but only at high aluminum concentrations (IC50 = 1.2 and 2.1 mM for aluminum lactat...Continue Reading

References

Mar 1, 1976·Brain : a Journal of Neurology·D R CrapperS Quittkat
Jan 1, 1985·Acta Neuropathologica·G Y Wen, H M Wisniewski
Mar 1, 1989·Cellular and Molecular Neurobiology·I M ParhadP M Tran
Mar 1, 1986·Environmental Health Perspectives·P O Ganrot
Feb 1, 1985·Journal of Neurochemistry·W W SchlaepferU J Zimmerman
Jan 1, 1988·Trends in Biochemical Sciences·T L Macdonald, R B Martin
Apr 10, 1987·Science·T L MacdonaldR B Martin
Jan 1, 1987·Advances in Experimental Medicine and Biology·R A Nixon, S E Lewis
Apr 29, 1988·Biochemical and Biophysical Research Communications·K B Pierson, M A Evenson
Nov 1, 1988·Biochemistry·S Lefebvre, W E Mushynski
Apr 1, 1988·Brain Research·N A MumaD L Price
Jan 1, 1985·The Journal of Burn Care & Rehabilitation·P A FredellR J Trancik
Jun 1, 1985·Canadian Journal of Biochemistry and Cell Biology = Revue Canadienne De Biochimie Et Biologie Cellulaire·R E MajochaF M Benes
May 1, 1985·The Journal of Cell Biology·G S Bennett, C DiLullo
Jul 1, 1967·Journal of Neuropathology and Experimental Neurology·L J EmbreeJ Sjöstrand
Jan 1, 1983·The Journal of Pharmacy and Pharmacology·R W Fuller, K W Perry
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·R SimanG Lynch
Feb 1, 1983·Journal of Neurochemistry·B A BrownC A Marotta
Aug 1, 1984·Journal of Neurochemistry·R A Nixon, C A Marotta
Sep 1, 1984·Journal of Neuropathology and Experimental Neurology·A HiranoI Nakano
Aug 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·D G GrahamD C Anthony
Jan 1, 1981·Journal of Neurochemistry·B A BrownC A Marotta
Apr 1, 1965·Journal of Neuropathology and Experimental Neurology·I KLATZOE STREICHER

❮ Previous
Next ❯

Citations

Jan 16, 1999·Journal of Neuroscience Research·L S Yang, H Ksiezak-Reding
Jan 1, 1994·Acta Neuropathologica·J P Müller, A Bruinink
Apr 21, 1993·Molecular and Cellular Biochemistry·B ShiA Haug
Jan 1, 1993·Molecular Neurobiology·L C Doering
Aug 1, 1994·Molecular Neurobiology·R F Itzhaki
Feb 1, 1995·Molecular and Chemical Neuropathology·T B Shea
Feb 1, 1992·Molecular and Chemical Neuropathology·P ZattaM Favarato
Jan 1, 1994·Archives of Toxicology·A HaugV Vitorello
Jul 14, 1995·Clinica Chimica Acta; International Journal of Clinical Chemistry·G FalkousD Mantle
Nov 1, 1992·The International Journal of Biochemistry·H Zhang, P Johnson
Jan 1, 1993·Progress in Neurobiology·H MeiriA Rousseau
May 24, 1994·Proceedings of the National Academy of Sciences of the United States of America·M HollósiG D Fasman
Nov 21, 2007·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Noriyuki KimuraEisaku Ohama
Oct 1, 1992·Pharmacology & Toxicology·B Shi, A Haug
Jun 1, 1992·Journal of Neurochemistry·J F LeterrierJ Ulrich
May 1, 1996·Neurochemical Research·M Camargo-De-MoraisC A Netto
Jan 9, 2020·Journal of the Royal Society, Interface·Axel PetzoldSonia O'Connor
Dec 15, 1994·Annals of the New York Academy of Sciences·R A NixonM Beermann
Dec 26, 2001·Chemical Reviews·A Y Louie, T J Meade
Nov 19, 1993·Brain Research·C W ScottC B Caputo
Jun 23, 2009·Brain Research Bulletin·Rodolphe Perrot, Joël Eyer
Oct 6, 1998·Neurochemistry International·S Guo-RossS C Bondy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.